Gait May Predict Alzheimer's Onset
the Neurology Advisor take:
The gait of an older adult may be an indicator of whether or not they develop Alzheimer’s disease later on.
Natalia del Campo, PhD, of Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, France, and colleagues examined 128 people, average age of 76 years old, without dementia but considered at high risk for it due to memory problems. Positron emission tomography scans were conducted, and 48% of participants had levels of beta-amyloid high enough to be associated with dementia.
Researchers also tested the subjects’ thinking and memory skills, as well as their ability to complete everyday tasks. Mild cognitive impairment was found in 46% of particpants.
The participants’ walking speed was also measured. There was a link between slow walking speed and amyloid levels in certain areas of the brain, including one responsible for motor functions, the researchers reported in the journal Neurology.
After comparing the speed participants walked with and without accounting for amyloid buildup, the researchers found up to 9% of the difference was the result of amyloid levels. However, the connection between amyloid and walking speed was not altered when accounting for age, education, or extent of memory problems.
“It’s possible that having subtle walking disturbances in addition to memory concerns may signal Alzheimer's disease, even before people show any clinical symptoms,” Dr. del Campo said in a statement.
Gait May Predict Alzheimer's Onset
The speed at which elderly people walk may indicate their likelihood of developing Alzheimer's disease, according to research published in Neurology.
Researchers led by Natalia del Campo, PhD, of the Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, in France, hypothesized that a slower speed of walking may be related to the amount of amyloid plaque people with Alzheimer's have built up in their brains, even if they do not yet have external symptoms of Alzheimer's disease.
Amyloid precursor protein (APP) occurs throughout the body. The amyloid hypothesis proposes that there is a fault with the processing of APP in the brain, leading to the production of a short fragment of APP, a sticky protein known as beta-amyloid.
Next Article in Neurodegenerative Diseases
Neurology Advisor Articles
- OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms
- History of Migraine Associated With Higher Risk for Cochlear Disorders
- Patent Foramen Ovale Closure for Stroke Prevention: Key Principles for Clinical Practice
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- A Model for Predicting Quality of Life Improvements After Deep Brain Stimulation
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- First-in-Class Therapy Approved for Polyneuropathy Caused by hATTR
- High Anxiety Symptoms Prevalent in Epilepsy, Mesial Temporal Sclerosis
- Advance Care Planning Doesn't Aid Quality of Life
- Variation in Specialty Drug Coverage Across Health Plans
- Alcohol Exposure Via Breastmilk May Affect Infant Development